Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MGNX - MacroGenics: Facing Considerable Headwinds From Unsatisfactory Trials

MGNX - MacroGenics: Facing Considerable Headwinds From Unsatisfactory Trials

MacroGenics Inc.
  • MGNX has an approved drug that isn't doing too well.
  • OS data for the drug in the approved indication was poor.
  • The company is not adequately derisked right now.

For further details see:

MacroGenics: Facing Considerable Headwinds From Unsatisfactory Trials
Stock Information
Company Name: MacroGenics Inc.
Stock Symbol: MGNX
Market: NASDAQ
Website: macrogenics.com
Menu
MGNX MGNX Quote MGNX Short MGNX News MGNX Articles MGNX Message Board
Get MGNX Alerts

News, Short Squeeze, Breakout and More Instantly...